Heron Therapeutics, Inc. (NASDAQ: HRTX)
$1.5250
-0.0050 ( +2.35% ) 1.7M
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Market Data
Open
$1.5250
Previous close
$1.5300
Volume
1.7M
Market cap
$232.71M
Day range
$1.4900 - $1.5450
52 week range
$1.0400 - $3.9300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k | Annual reports | 76 | Mar 12, 2024 |
| 8-k | 8K-related | 13 | Mar 12, 2024 |
| 8-k | 8K-related | 13 | Jan 24, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |